Sa12b和BMP7修饰的功能化自组装多肽水凝胶材料修复椎间盘退变的应用基础研究
批准号:
82072492
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
陶晖
依托单位:
学科分类:
骨、关节、软组织退行性病变
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
陶晖
中文摘要
椎间盘退变是引起颈腰痛的主要病因。临床以对“症”治疗为主,而非对“因”治疗。组织工程髓核可促进髓核细胞再生,有望实现对“因”治疗。但现有组织工程髓核均未考虑椎间盘退变后微环境改变对其影响,导致体内与体外的实验结果存在巨大差异。椎间盘退变微环境的改变会抑制细胞生物学活性。我们前期研究发现,这些微环境中以酸环境的抑制作用最为显著,且通过酸离子敏感通道发挥效应。因此,构建一种可克服酸环境的组织工程髓核是治疗关键。RADA16是一种可体内自组装成水凝胶的多肽材料,在其C末端插入特殊功能的短肽可构建组织特异性多肽材料。为此,我们拟将酸离子敏感通道的阻滞剂Sa12b与RADA16结合构建功能化多肽RAD/SA1,观察其材料特性、生物相容性、体外和体内生物活性及作用机制。此外,再将其与我们前期利用BMP7构建的多肽RAD/KPS混合,观察两者的协同作用,从而为椎间盘退变的修复提供新的思路和方法。
英文摘要
Intervertebral disc (IVD) degeneration is the main pathological basis of neck pain and low back pain. Clinical treatment is mainly for "symptoms" rather than "causes". Tissue engineering of nucleus pulposus can promote the regeneration of nucleus pulposus cells, which is expected to achieve the "causes" treatment. However, the effect of microenvironment changes during disc degeneration has not been considered in the existing tissue-engineered nucleus pulposus, resulting in great differences between the experimental results in vivo and in vitro. Many studies had shown that the changes of microenvironment of disc degeneration could inhibit the biological activity of cells. In our previous studies, we found that the inhibition of acid environment is the most significant, and it plays an effect through acid ion sensitive channels (AISCs). Therefore, the key of IVD degeneration treatment is to construct a tissue-engineered nucleus pulposus which can overcome the acid environment. RADA16-I is one kind of polypeptide material which can be self-assembled into hydrogel in vivo. The special peptide can be constructed by inserting special peptide at the C end. Therefore, we designed a new functionalized peptide RAD/SA1 that conjugated the short functional motifs, Sa12b, the inhibitor of AISCs, onto the C-terminus of RADA16-I. Then, the its material characteristics, biocompatibility, the effect and mechanism for nucleus pulposus mesenchymal stem cells in vitro and the effect and mechanism for IVD degeneration in vivo were detected. In addition, another functionalized peptide RAD/SA1/KPS was designed by mixed RAD/SA1 with the peptide RAD / KPS which was conjugated a short functional motif of BMP7 onto the C-terminus of RADA16-I in our precious studies. Then, the synergistic effect of RAD/SA1/KPS on IVD was further observed. This study would not only provide a new concept of the construction of tissue engineering of nucleus pulposus, but also provide a new therapeutic method for IVD degeneration.
椎间盘退变是引起颈腰痛的主要病因。临床以对“症”治疗为主,而非对“因”治疗。组织工程髓核可促进髓核细胞再生,有望实现对“因”治疗。椎间盘退变后,其微环境会发生改变。但现有组织工程髓核均未考虑椎间盘退变后微环境改变对其影响,导致体内与体外的实验结果存在巨大差异。椎间盘退变微环境的改变对干细胞的生物学活性有重大影响,其中以低pH抑制作用最为显著,且主要通过ASICs信号通路发挥作用。因此,构建一种可克服酸环境的组织工程髓核是治疗的关键。为此,本课题将ASICs的短肽抑制剂Sa12b与RADA16-I结合,期望构建一种可以适合酸环境的支架材料。本研究首先将Sa12b与RADA16-I结合构建新型功能化自组装多肽RAD/SA1。其次,将其与含有BMP7短功能片段的RAD/KPS混合后,形成另一种支架材料RAD/SA1/KPS。再次,通过体外实验观察RAD/SA1和RAD/SA1/KPS对人退变NP-MSCs的生物相容性和生物学活性。然后,通过动物实验观察RAD/SA1和RAD/SA1/KPS对新西兰兔椎间盘退变的修复作用。最后,从Ca2+/MAPK 信号通路探讨其作用机制。通过研究发现:1)可成功构建RAD/SA1和RAD/SA1/KPS,并均能自组装成纳米纤维水凝胶支架材料;2)RAD/SA1和RAD/SA1/KPS均对NP-MSCs在体外和体内均具有良好的生物学相容性,而且体外可促进人退变NP-MSCs的增殖及相关功能蛋白和基因表达(II型胶原、蛋白多糖、Sox-9)。3)RAD/SA1和RAD/SA1/KPS均可修复新西兰兔椎间盘的退变,其中RAD/SA1/KPS的作用更为显著。4)RAD/SA1和RAD/SA1/KPS可能主要是通过Ca2+/PI3K/AKT或者Ca2+/p-ERK信号通路发挥作用。综上所述,RAD/SA1和RAD/SA1/KPS可克服酸环境修复椎间盘的退变,且RAD/SA1和RAD/KPS混合后具有协同作用,效果更佳。通过本研究,不仅为椎间盘退变的生物学治疗提供了两种新型支架材料,而且为今后椎间盘退变生物支架材料的设计提供了新的思路和方法。
椎间盘退变微环境介导的人髓核间充质干细胞的“静默”作用及其机制探讨
-
批准号:81601935
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:陶晖
-
依托单位:
国内基金
海外基金